Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.


TSXV:SBM - Post by User

Comment by tylerreddickon Jun 18, 2024 7:46pm
82 Views
Post# 36095114

RE:RE:This sounds pretty good to me

RE:RE:This sounds pretty good to me" In the quest to combat age-related skin concerns, we believe two groundbreaking topical agents, Pitera™ and GlycoProteMim™, will emerge as potential frontrunners. Both Pitera™ and GlycoProteMim™ represent significant strides in the field of dermatology, offering promising solutions to age-related skin issues. Pitera™, with its nutrient-rich profile, enhances skin vitality and youthfulness, while GlycoProteMim™ brings robust anti-aging effects inspired by nature's own survival mechanisms. As research progresses, the synergistic incorporation of these ingredients could potentially redefine the standards of topical treatments for age-related skin concerns, heralding a new era of youthful, resilient skin."
<< Previous
Bullboard Posts
Next >>